480 related articles for article (PubMed ID: 8110236)
1. Comment: Persistence of Mycobacterium leprae in the peripheral nerves of multidrug-treated leprosy patients.
Grange JM; Beck JS; Abbot NC
Lepr Rev; 1993 Sep; 64(3):280. PubMed ID: 8110236
[No Abstract] [Full Text] [Related]
2. Persistence of Mycobacterium leprae in the peripheral nerve as compared to the skin of multidrug-treated leprosy patients.
Shetty VP; Suchitra K; Uplekar MW; Antia NH
Lepr Rev; 1992 Dec; 63(4):329-36. PubMed ID: 1479872
[TBL] [Abstract][Full Text] [Related]
3. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
Job CK; Jayakumar J; Aschhoff M; Mathan MM
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
[TBL] [Abstract][Full Text] [Related]
4. A plea to revive skin smear examination.
Porichha D
Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2):116-9. PubMed ID: 11757169
[No Abstract] [Full Text] [Related]
5. Supervised administration of multidrug therapy in leprosy colonies through volunteers--a bacteriological assessment.
Ganapati R; Naik SS; Revankar CR; Vartak RB; Desai AP; Panvalkar NA; Deshpande SS
Indian J Lepr; 1986; 58(1):86-90. PubMed ID: 3528338
[No Abstract] [Full Text] [Related]
6. Persisting Mycobacterium leprae among THELEP trial patients in Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
Lepr Rev; 1987 Dec; 58(4):325-37. PubMed ID: 3323750
[No Abstract] [Full Text] [Related]
7. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen.
Jamet P; Ji B
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):622. PubMed ID: 7868967
[No Abstract] [Full Text] [Related]
8. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
9. Incidence of nerve damage in leprosy patients treated with MDT.
Solomon S; Kurian N; Ramadas P; Rao PS
Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):451-6. PubMed ID: 10347565
[TBL] [Abstract][Full Text] [Related]
10. The bacteriological examination of slit-skin smears in leprosy control programmes using multiple drug therapy: a plea for radical changes in current operational methodology.
Georgiev GD; McDougall AC
Indian J Lepr; 1987; 59(4):373-85. PubMed ID: 3330552
[No Abstract] [Full Text] [Related]
11. Higher incidence of viable Mycobacterium leprae within the nerve as compared to skin among multibacillary leprosy patients released from multidrug therapy.
Shetty VP; Suchitra K; Uplekar MW; Antia NH
Lepr Rev; 1997 Jun; 68(2):131-8. PubMed ID: 9217352
[TBL] [Abstract][Full Text] [Related]
12. [Multibacillary leprosy recurrences].
Rodríguez G; Pinto R; Laverde C; Sarmiento M; Riveros A; Valderrama J; Ordóñez N
Biomedica; 2004 Sep; 24(3):332-4. PubMed ID: 15551886
[No Abstract] [Full Text] [Related]
13. Skin smear examination in relation to multidrug therapy campaigns.
Bhatia VN
Indian J Lepr; 1987; 59(1):75-9. PubMed ID: 3302062
[No Abstract] [Full Text] [Related]
14. Relapse of leprosy after multidrug therapy.
Dasananjali K
J Med Assoc Thai; 1996 Oct; 79(10):635-9. PubMed ID: 8996998
[TBL] [Abstract][Full Text] [Related]
15. Problems of multidrug therapy.
Ramu G
Indian J Lepr; 1991; 63(3-4):435-45. PubMed ID: 1804896
[No Abstract] [Full Text] [Related]
16. Persistence of Mycobacterium leprae in the peripheral nerve.
Antia NH; Nedugayil K
Indian J Med Res; 1983 Apr; 77():420-2. PubMed ID: 6347881
[No Abstract] [Full Text] [Related]
17. A colorimetric PCR method for the detection of M. leprae in skin biopsies from leprosy patients.
Jamil S; Wilson SM; Hacket M; Hussain R; Stoker NG
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):512-20. PubMed ID: 7868947
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic regimens in leprosy.
Pattyn SR
Verh K Acad Geneeskd Belg; 1990; 52(4):301-10; discussion 310-2. PubMed ID: 2077778
[TBL] [Abstract][Full Text] [Related]
19. Multidrug therapy--the pathway for global leprosy elimination.
al-Qubati Y; al-Kubati AS
Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482
[TBL] [Abstract][Full Text] [Related]
20. [How should leprosy be treated?].
Mahé A
Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
[No Abstract] [Full Text] [Related]
[Next] [New Search]
